Short term clinical outcomes of the combined eyeWatch™ implant and eyePlate in refractory glaucoma—a United Kingdom dual centre study
The eyeWatch™ system allows for peri and postoperative non-invasive adjustments to resistance of aqueous humour outflow. At 12 months the majority of patients experienced adequate intraocular pressure control, with over 47% not requiring anti-glaucoma medications.
Authors
- Andrew J. Swampillai (ORCID: https://orcid.org/0000-0003-0773-0009)
- Kin Sheng Lim (ORCID: https://orcid.org/0000-0002-3897-1633)
- Leon Au (ORCID: https://orcid.org/0000-0002-9624-1890)
Institutions
- Manchester Royal Eye Hospital (GB)
- Manchester University NHS Foundation Trust (GB)
Publication Details
- Journal
- International Ophthalmology
- Published
- 2025-06-24
- DOI
- https://doi.org/10.1007/s10792-025-03573-8
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00